Crossmark

Co-treatment Strategy Supports Neuroprotection by Intersecting p62-Keap1-NRF2 and Autophagy Signaling Pathways in the Cellular Model of Parkinson's Disease

Crossref DOI link: https://doi.org/10.1007/s10571-025-01610-9

Published Online: 2025-10-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koszła, Oliwia https://orcid.org/0000-0003-2160-9424
Sołek, Przemysław https://orcid.org/0000-0002-6194-0042
Jóźwiak, Krzysztof https://orcid.org/0000-0001-6018-5092
Funding

Funding for this research was provided by:

Uniwersytet Medyczny w Lublinie (PBmb340)
License Information

Text and Data Mining valid from 2025-10-16

Version of Record valid from 2025-10-16
More Information

Article History

Received: 28 July 2025

Accepted: 14 September 2025

First Online: 16 October 2025

Declarations

:

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below